Unknown PHASE2 INTERVENTIONAL NCT01441505

A Study of Ketamine as an Antidepressant

Sponsor: The University of New South Wales

Interventions Ketamine Saline or Midazolam (active placebo)

Updated 6 times since 2017 Last updated: Feb 20, 2013 Started: Sep 30, 2011 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01441505, this PHASE2 trial focuses on Major Depressive Episode and remains ongoing. Sponsored by The University of New South Wales, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Dec 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jun 2018 — Dec 2018 [monthly]

Unknown Status PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The University of New South Wales
Wesley Mission

Data source: The University of New South Wales

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kogarah, Australia